Wed, February 16, 2011
Tue, February 15, 2011
Mon, February 14, 2011
Fri, February 11, 2011
Thu, February 10, 2011
Wed, February 9, 2011
Tue, February 8, 2011
Mon, February 7, 2011
[ Mon, Feb 07th 2011 ] - Market Wire
00 A.M. EST
Sun, February 6, 2011
Fri, February 4, 2011
Thu, February 3, 2011
Wed, February 2, 2011
Tue, February 1, 2011
Mon, January 31, 2011
Sun, January 30, 2011
Fri, January 28, 2011

Law Office of Brodsky & Smith, LLC Announces Investigation of Emergent Group, Inc.


//health-fitness.news-articles.net/content/2011/ .. nounces-investigation-of-emergent-group-inc.html
Published in Health and Fitness on Tuesday, February 8th 2011 at 18:01 GMT by Market Wire   Print publication without navigation


BALA CYNWYD, Pa.--([ BUSINESS WIRE ])--Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Emergent Group, Inc. (aEmergenta or the aCompanya) (AMEX:LZR) relating to the proposed acquisition by Universal Hospital Services, Inc. (aUHSa).

Under the terms of the transaction, Emergent shareholders would receive $8.46 in cash for each share of common stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Emergent by not acting in Emergent shareholders' best interests in connection with the sale process to UHS. The transaction may undervalue Emergent as Emergent stock traded at $8.95 per share on March 19, 2010.

If you own shares of Emergent stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at [ investorrelations@brodsky-smith.com ], visiting [ http://brodsky-smith.com/260-lzr-emergent-group-inc.html ], or by calling toll free 877-LEGAL-90.


Publication Contributing Sources